Table 4. Tumor marker levels, ESR, RMI and PDI in patients with adnexal masses (x̄±s).
| Indices | Tumors |
||||
|---|---|---|---|---|---|
| Benignant | Borderline | Malignant | Total | ||
| CA125 (IU/L) | 59.45±217.44 | 281.06±317.20 | 973.13±2,804.92 | 641.06±2,543.97 | |
| CA19-9 (IU/L) | 23.41±53.18 | 25.11±40.77 | 60.68±257.95 | 52.85±224.66 | |
| CEA (IU/L) | 1.80±1.98 | 2.28±1.26 | 5.36±10.81 | 2.83±5.97 | |
| CA15-3 (IU/L) | 18.95±10.12 | 11.83±2.17 | 163.51±442.87 | 75.83±289.41 | |
| ESR | 19.88±17.46 | 26.50±23.55 | 40.16±27.44 | 35.17±27.66 | |
| RMI | 167.57±529.68 | 1,708.39±2,116.67 | 4,214.74±9,497.03 | 3,065.54±9,171.39 | |
| PDI | 0.32±0.06 | 0.35±0.12 | 0.69±0.11 | 0.59±0.19 | |
Referral values for examined tumor markers and ESR, CA125, 0-35 IU/L; CA19-9, 0-27 IU/L; CEA, 0-3.8 IU/L; CA15-3, 0-42 IU/L; ESR, up to 10 in the first hour